2 Top Healthcare Stocks to Buy in February
Will the healthcare sector finally rebound in 2026, after underperforming broader equities in recent years? It's hard to know for sure. But rather than avoiding the entire industry because of recent history, it's worth looking at individual healthcare stocks with strong prospects and buying them right now.
Two attractive candidates to consider are CVS Health (NYSE: CVS) and Vertex Pharmaceuticals (NASDAQ: VRTX).
Image source: Getty Images.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
374,90 €
1,49 %
Einseitige Meinung: Vertex Pharmaceuticals Inc. erhält nur Buy-Einschätzungen und keine Sell-Einschätzungen.
Das von der Community festgelegte Kursziel von 461 € für Vertex Pharmaceuticals Inc. bedeutet eine mögliche Steigerung um über 20% im Vergleich zu 374.9 €.
